Jefferies Group’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-27,236
| Closed | -$19M | – | 1798 |
|
|
2022
Q1 | $19M | Buy |
27,236
+19,197
| +239% | +$12.1M | 0.12% | 133 |
|
|
2021
Q4 | $5.08M | Sell |
8,039
-161
| -2% | -$99K | 0.03% | 448 |
|
|
2021
Q3 | $4.96M | Sell |
8,200
-9,404
| -53% | -$5.84M | 0.04% | 437 |
|
|
2021
Q2 | $9.83M | Buy |
17,604
+7,056
| +67% | +$3.57M | 0.06% | 277 |
|
|
2021
Q1 | $4.99M | Sell |
10,548
-6,308
| -37% | -$3.07M | 0.04% | 381 |
|
|
2020
Q4 | $8.14M | Buy |
16,856
+7,183
| +74% | +$3.88M | 0.06% | 275 |
|
|
2020
Q3 | $5.42M | Buy |
9,673
+2,886
| +43% | +$1.75M | 0.06% | 268 |
|
|
2020
Q2 | $4.23K | Buy |
6,787
+6,740
| +14,340% | +$3.83M | 0.05% | 314 |
|
|
2020
Q1 | $23K | Buy |
47
+15
| +47% | +$6.19K | ﹤0.01% | 1928 |
|
|
2019
Q4 | $12K | Sell |
32
-4,693
| -99% | -$1.58M | ﹤0.01% | 2491 |
|
|
2019
Q3 | $1.31M | Sell |
4,725
-1,293
| -21% | -$383K | 0.01% | 1349 |
|
|
2019
Q2 | $1.88M | Buy |
+6,018
| New | +$2M | 0.01% | 955 |
|
|
2018
Q4 | – | Sell |
-552
| Closed | -$223K | – | 2488 |
|
|
2018
Q3 | $223K | Sell |
552
-2,850
| -84% | -$1.08M | ﹤0.01% | 2054 |
|
|
2018
Q2 | $1.17M | Buy |
3,402
+1,816
| +115% | +$568K | 0.01% | 1171 |
|
|
2018
Q1 | $546K | Sell |
1,586
-4,870
| -75% | -$1.69M | ﹤0.01% | 1464 |
|
|
2017
Q4 | $2.43M | Buy |
6,456
+6,357
| +6,421% | +$2.57M | 0.01% | 897 |
|
|
2017
Q3 | $44K | Sell |
99
-7,699
| -99% | -$3.66M | ﹤0.01% | 2222 |
|
|
2017
Q2 | $3.83M | Buy |
7,798
+6,570
| +535% | +$2.88M | 0.03% | 645 |
|
|
2017
Q1 | $476K | Buy |
1,228
+876
| +249% | +$325K | ﹤0.01% | 1611 |
|
|
2016
Q4 | $129K | Buy |
352
+112
| +47% | +$42.6K | ﹤0.01% | 1984 |
|
|
2016
Q3 | $96K | Sell |
240
-1,980
| -89% | -$794K | ﹤0.01% | 2039 |
|
|
2016
Q2 | $775K | Sell |
2,220
-4,865
| -69% | -$1.87M | ﹤0.01% | 1235 |
|
|
2016
Q1 | $2.55M | Buy |
7,085
+2,635
| +59% | +$1.09M | 0.01% | 739 |
|
|
2015
Q4 | $2.42M | Buy |
+4,450
| New | +$2.41M | 0.01% | 792 |
|
|
2015
Q3 | – | Sell |
-50
| Closed | -$26K | – | 2894 |
|
|
2015
Q2 | $26K | Sell |
50
-614
| -92% | -$300K | ﹤0.01% | 2577 |
|
|
2015
Q1 | $300K | Buy |
+664
| New | +$281K | ﹤0.01% | 1599 |
|
|
2014
Q4 | – | Sell |
-646
| Closed | -$233K | – | 2273 |
|
|
2014
Q3 | $233K | Sell |
646
-4,255
| -87% | -$1.43M | ﹤0.01% | 1745 |
|
|
2014
Q2 | $1.38M | Buy |
+4,901
| New | +$1.45M | 0.01% | 774 |
|
|
2014
Q1 | – | Sell |
-3,920
| Closed | -$1.08M | – | 2332 |
|
|
2013
Q4 | $1.08M | Buy |
3,920
+2,761
| +238% | +$794K | 0.01% | 795 |
|
|
2013
Q3 | $363K | Sell |
1,159
-19,756
| -94% | -$5.2M | ﹤0.01% | 1346 |
|
|
2013
Q2 | $4.7M | Buy |
+20,915
| New | +$4.87M | 0.05% | 270 |
|
Other funds holding REGN
Jefferies Group's REGN Position: Q2 2022 in Review
Jefferies Group sold out of Regeneron Pharmaceuticals (REGN) in Q2 2022, closing a stake of 27,236 shares — an estimated $19M sold.
Jefferies Group first reported a position in REGN in Q2 2013 and held it in 31 quarters. The position peaked at $19M in Q1 2022. 1,063 funds tracked by Wall St. Rank hold REGN as of Q2 2022.
- Jefferies Group reported no remaining Regeneron Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
- Jefferies Group sold 27,236 Regeneron Pharmaceuticals shares in Q2 2022, an estimated $19M.
- Jefferies Group first reported a position in Regeneron Pharmaceuticals in Q2 2013 and held it in 31 quarters.
- Jefferies Group's Regeneron Pharmaceuticals position peaked at $19M in Q1 2022.
- 1,063 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2022.
Based on Jefferies Group's 13F filing for Q2 2022, filed 15 Aug 2022.